)
WELL Health Technologies (WELL) investor relations material
WELL Health Technologies Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record annual revenue of CAD 1.4 billion ($1.40B) in FY2025, up 52% year-over-year, with Adjusted EBITDA of CAD 203.7 million ($203.7M), up 336%, and Adjusted Net Income of CAD 126.5 million ($0.50 per share), up 1,479% year-over-year.
Delivered 10.5 million care interactions, 4.3 million Canadian patient visits, and expanded to 252 clinics nationwide, adding 44 clinics and 307 providers in 2025 through M&A.
WELLTRUST platform launched, enabling AI-powered patient identification for clinical research, with 30,000 patient consents and 56 clinics live.
Strategic review of U.S. assets underway, with active divestiture discussions for WISP, Circle Medical, and CRH.
WELLSTAR subsidiary delivered strong SaaS growth and is planned for a spin-out to unlock shareholder value.
Financial highlights
Normalized 2025 revenue was CAD 1.35 billion ($1.35B), up 34% year-over-year, with Normalized Adjusted EBITDA of CAD 148.6 million ($148.6M), up 17%, and Normalized Adjusted Net Income of CAD 99 million, up 102%.
Adjusted EBITDA margin improved to 14.5% from 5.1% in 2024; Adjusted Gross Margin reached 44.2% in 2025.
Free cash flow attributable to shareholders was CAD 58.2 million ($58.2M), up 19% year-over-year.
WELLSTAR revenue grew 63% to CAD 72.9 million ($72.9M), with 30% Adjusted EBITDA margin.
HEALWELL contributed CAD 112.9 million in revenue, with Q4 revenue up 374% year-over-year and positive Adjusted EBITDA.
Outlook and guidance
2026 revenue guidance: CAD 1.55–1.65 billion ($1.55–$1.65B), with Adjusted EBITDA of CAD 175–185 million ($175–$185M), targeting at least 10% annual growth in Adjusted EBITDA and free cash flow.
WELL Canada targeting over CAD 800 million ($800M) in revenue and CAD 100 million ($100M) in Adjusted EBITDA within 18 months.
Guidance excludes unannounced M&A and is sensitive to timing of acquisitions and divestitures.
Continued focus on Canadian M&A and planned WELLSTAR spin-out, subject to market conditions.
- All AGM motions passed, with a June 18 investor day announced for further engagement.WELL
AGM 20243 Feb 2026 - Record Q2 revenue, raised guidance, and AI-driven strategy fuel strong growth and profitability.WELL
Q2 20241 Feb 2026 - Record Q3-2024 revenue and EBITDA growth, raised guidance, and robust M&A pipeline support outlook.WELL
Q3 202415 Jan 2026 - Record revenue, strong Canadian growth, and robust 2025 outlook despite one-time impacts.WELL
Q4 20242 Dec 2025 - Record Q2 revenue and EBITDA growth driven by acquisitions and digital health expansion.WELL
Q2 202523 Nov 2025 - Q1 revenue up 32% to $294.1M, net loss $41.9M, Canadian focus and strong 2025 outlook.WELL
Q1 202518 Nov 2025 - Record Q3 revenue and EBITDA, strong Canadian growth, and robust M&A pipeline for 2025.WELL
Q3 202513 Nov 2025 - WELL Health leverages technology, AI, and capital discipline to drive growth and unlock shareholder value.WELL
Investor Day 2024 Presentation13 Jun 2025
Next WELL Health Technologies earnings date
Next WELL Health Technologies earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)